These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
551 related items for PubMed ID: 19177449
1. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients. Nashan B, Saliba F, Durand F, Barcéna R, Herrero JI, Mentha G, Neuhaus P, Bowles M, Patch D, Bernardos A, Klempnauer J, Bouw R, Ives J, Mamelok R, McKay D, Truman M, Marotta P. Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449 [Abstract] [Full Text] [Related]
3. The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy. Grinyó JM, Ekberg H, Mamelok RD, Oppenheimer F, Sánchez-Plumed J, Gentil MA, Hernandez D, Kuypers DR, Brunet M. Nephrol Dial Transplant; 2009 Jul; 24(7):2269-76. PubMed ID: 19357111 [Abstract] [Full Text] [Related]
4. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine. Lobritto SJ, Rosenthal P, Bouw R, Leung M, Snell P, Mamelok RD. Liver Transpl; 2007 Nov; 13(11):1570-5. PubMed ID: 17969194 [Abstract] [Full Text] [Related]
5. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation. Mardigyan V, Tchervenkov J, Metrakos P, Barkun J, Deschenes M, Cantarovich M. Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819 [Abstract] [Full Text] [Related]
6. Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients. Kuypers DR, Claes K, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y. J Clin Pharmacol; 2003 Aug; 43(8):866-80. PubMed ID: 12953344 [Abstract] [Full Text] [Related]
11. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil. Beckebaum S, Armstrong VW, Cicinnati VR, Streit F, Klein CG, Gerken G, Paul A, Oellerich M. Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937 [Abstract] [Full Text] [Related]
12. Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation. Mourad M, Malaise J, Chaib Eddour D, De Meyer M, König J, Schepers R, Squifflet JP, Wallemacq P. Clin Chem; 2001 Apr; 47(7):1241-8. PubMed ID: 11427455 [Abstract] [Full Text] [Related]
14. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients. Chen YH, Zheng KL, Chen LZ, Dai YP, Fei JG, Qiu J, Li J. Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090 [Abstract] [Full Text] [Related]